Loading clinical trials...
Loading clinical trials...
Allogenic Adipose Tissue Derived-MSCs Therapy in Patients With Connective Tissue Diseases-associated Interstitial Lung Disease(CTD-ILD): Phase I/IIa Clinical Trial
Conditions
Interventions
ADSC01
Locations
1
Taiwan
China Medical University Hospital
Taichung, Taiwan
Start Date
August 20, 2024
Primary Completion Date
January 7, 2025
Completion Date
May 30, 2026
Last Updated
August 28, 2024
NCT05746039
NCT06329401
NCT07451977
NCT07484243
NCT06817590
NCT04778046
Lead Sponsor
China Medical University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions